PlainRecalls
FDA Devices Moderate Class II Ongoing

Ambu VivaSight 2 DLT; endobronchial tube system used for verifying tube placement and repositioning. Catalog numbers 412351000, 412371000, 412391000, 412411000

Reported: July 27, 2022 Initiated: June 3, 2022 #Z-1420-2022

Product Description

Ambu VivaSight 2 DLT; endobronchial tube system used for verifying tube placement and repositioning. Catalog numbers 412351000, 412371000, 412391000, 412411000

Reason for Recall

Firm has received complaints on the device concerning leak/rupture of either the bronchial or tracheal cuff. Leakage during procedure could lead to loss of secure airway and will require re-intubation of patient.

Details

Recalling Firm
Ambu Inc.
Units Affected
12,921
Distribution
Domestic distribution nationwide. Foreign distribution to Austria, Belgium, Cyprus, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norge, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK Canada, Australia, New Zealand, Israel .
Location
Columbia, MD

Frequently Asked Questions

What product was recalled?
Ambu VivaSight 2 DLT; endobronchial tube system used for verifying tube placement and repositioning. Catalog numbers 412351000, 412371000, 412391000, 412411000. Recalled by Ambu Inc.. Units affected: 12,921.
Why was this product recalled?
Firm has received complaints on the device concerning leak/rupture of either the bronchial or tracheal cuff. Leakage during procedure could lead to loss of secure airway and will require re-intubation of patient.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 27, 2022. Severity: Moderate. Recall number: Z-1420-2022.